What is the recommended dosage and treatment approach for migraines using triptans (tryptans)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Triptans for Migraine Treatment

Triptans should be used as second-line therapy for moderate to severe migraines or mild to moderate migraines unresponsive to NSAIDs, with oral sumatriptan 50-100mg, rizatriptan 10mg, or zolmitriptan 2.5-5mg as the preferred initial choices, taken early in the attack when headache is still mild. 1

Treatment Algorithm

When to Use Triptans

  • Reserve triptans for patients with moderate to severe migraines or those with mild to moderate migraines that fail to respond to first-line NSAIDs (aspirin, ibuprofen, naproxen, or diclofenac) 1

  • Use triptans as second-line therapy after over-the-counter analgesics provide inadequate relief 1

Specific Dosing Recommendations

Oral Formulations (Standard First Choice):

  • Sumatriptan: 25-100mg orally every 2 hours; maximum 200mg per day 1
  • Rizatriptan: 5-20mg orally every 2 hours; maximum 30mg per day (reaches peak concentration in 60-90 minutes, faster than most other triptans) 1
  • Zolmitriptan: 1.25-5mg initially; may repeat after 2 hours; maximum 10mg per 24 hours 2
  • Eletriptan: 20-40mg initially; may repeat after 2 hours; maximum 80mg per day 3
  • Naratriptan: 1.0-2.5mg orally every 4 hours; maximum 5mg per day (longest half-life, may reduce recurrence) 1

Non-Oral Routes (For Rapid Relief or When Nausea/Vomiting Present):

  • Subcutaneous sumatriptan: 6mg SC, may repeat in 1 hour; maximum 12mg per 24 hours (reaches peak in 15 minutes, 70-82% effective—fastest and most effective route) 1
  • Intranasal sumatriptan: 5-10mg (one to two sprays) in one nostril; may repeat after 2 hours; maximum 40mg per day 1
  • Orally disintegrating tablets: Rizatriptan MLT or zolmitriptan for patients who cannot swallow pills or prefer not to use liquids 1, 4

Critical Timing Principles

  • Administer triptans early in the attack when headache is still mild for maximum effectiveness 1

  • Do NOT use triptans during the aura phase—no evidence supports this approach 1

  • If headache recurs within 8-12 hours, a second dose may be administered at the specified interval for each medication 1

  • Limit acute treatment to no more than twice per week to prevent medication-overuse headache 1

Trial-and-Error Strategy

  • Trial each triptan for 2-3 headache episodes before abandoning that medication 1

  • If one triptan fails, try a different triptan—non-responders to one may benefit from another 1

  • Match drug characteristics to patient needs: Consider onset speed, duration of action, and route of administration based on attack characteristics 1

Managing Recurrence

  • Upon relapse (return of symptoms within 48 hours), patients may repeat the triptan dose or combine with fast-acting NSAIDs (naproxen sodium, ibuprofen lysine, or diclofenac potassium) 1

  • Naratriptan may have lower recurrence rates due to its longer half-life, though evidence is speculative 1

Absolute Contraindications

Do not prescribe triptans in patients with: 1

  • Ischemic vascular conditions or coronary artery disease
  • Vasospastic coronary disease
  • Uncontrolled hypertension
  • Hemiplegic or basilar migraine
  • Recent use (within 24 hours) of ergotamine derivatives or another triptan
  • Concurrent MAOI use

Special Populations

Hepatic impairment: Use zolmitriptan 1.25mg (half of 2.5mg tablet); maximum 5mg per day in severe hepatic impairment 2

Cimetidine co-administration: Limit zolmitriptan to maximum 2.5mg single dose, not exceeding 5mg per 24 hours 2

Common Pitfalls to Avoid

  • Avoid using triptans too late in the attack—efficacy decreases significantly once central sensitization develops 4

  • Do not combine triptans with ergotamine derivatives within 24 hours due to additive vasoconstrictive effects 1

  • Recognize that subcutaneous sumatriptan has the highest therapeutic gain (51%) compared to oral formulations (29-37%), making it the best choice when rapid, reliable relief is essential 5

  • Consider non-oral routes when nausea/vomiting are prominent features (>90% of migraine patients experience nausea) 1, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.